AGP Picks
View all

News Break! Middle East
Provided by AGP

News Break! Middle East: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on News Break! Middle East.

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

November 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30

Press releases published on November 9, 2026

Silexion Therapeutics Announces 1-for-24 Reverse Share Split
Nov. 9, 2026

Silexion Therapeutics Announces 1-for-24 Reverse Share Split

Indeterminate GlobeNewswire
Zenas BioPharma to Present at the Jefferies London Global Healthcare Conference
Nov. 9, 2026

Zenas BioPharma to Present at the Jefferies London Global Healthcare Conference

Indeterminate GlobeNewswire
Marengo Presents Interim Phase 2 STARt-002 Results for First-in-Class Selective T-Cell Agonist Invikafusp Alfa Plus Sacituzumab Govitecan Across Two Metastatic Breast Cancer Cohorts in Oral Presentation at SITC 2026
Nov. 9, 2026

Marengo Presents Interim Phase 2 STARt-002 Results for First-in-Class Selective T-Cell Agonist Invikafusp Alfa Plus Sacituzumab Govitecan Across Two Metastatic Breast Cancer Cohorts in Oral Presentation at SITC 2026

Indeterminate GlobeNewswire
Fredonia Mining Appoints Global Mining Executive Gustavo Gomes as COO to Advance El Dorado–Monserrat Development
Nov. 9, 2026

Fredonia Mining Appoints Global Mining Executive Gustavo Gomes as COO to Advance El Dorado–Monserrat Development

Indeterminate GlobeNewswire
GoldInxs CEO Issues Letter to Shareholders, Highlights Progression of Maiden Drill Program at Fishpot Project
Nov. 9, 2026

GoldInxs CEO Issues Letter to Shareholders, Highlights Progression of Maiden Drill Program at Fishpot Project

Indeterminate GlobeNewswire
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2026 Financial Results 
Nov. 9, 2026

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2026 Financial Results 

Indeterminate GlobeNewswire
Ocular Therapeutix™ Reports Third Quarter 2026 Financial Results and Business Highlights
Nov. 9, 2026

Ocular Therapeutix™ Reports Third Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire
Kamada Declares Cash Dividend of $0.14 Per Share; The Company Continues its Record-High Year
Nov. 9, 2026

Kamada Declares Cash Dividend of $0.14 Per Share; The Company Continues its Record-High Year

Indeterminate GlobeNewswire
Mentari Therapeutics Announces Closing of Merger with InMed Pharmaceuticals and Previously Announced $490 Million Financing
Nov. 9, 2026

Mentari Therapeutics Announces Closing of Merger with InMed Pharmaceuticals and Previously Announced $490 Million Financing

Indeterminate GlobeNewswire
CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care
Nov. 9, 2026

CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care

Indeterminate GlobeNewswire
Tango Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights
Nov. 9, 2026

Tango Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights

Indeterminate GlobeNewswire
Can-Fite Reports Ten-Year Survival Milestone for Advanced Liver Cancer Patient from Phase II Namodenoson Study
Nov. 9, 2026

Can-Fite Reports Ten-Year Survival Milestone for Advanced Liver Cancer Patient from Phase II Namodenoson Study

Indeterminate GlobeNewswire
Medicenna Presents ABILITY-1 Data at SITC 2026 Showing 40% ORR in Gastrointestinal Cancer Patients with Biomarker Enriched Tumors Resistant to Approved Therapies
Nov. 9, 2026

Medicenna Presents ABILITY-1 Data at SITC 2026 Showing 40% ORR in Gastrointestinal Cancer Patients with Biomarker Enriched Tumors Resistant to Approved Therapies

Indeterminate GlobeNewswire
Codexis Advances ECO Synthesis Toward Adoption Readiness with Quality at Scale and Expanded siRNA Manufacturing Capabilities
Nov. 9, 2026

Codexis Advances ECO Synthesis Toward Adoption Readiness with Quality at Scale and Expanded siRNA Manufacturing Capabilities

Indeterminate GlobeNewswire
Practice Trade Memecoins and Win Real SOL with memeCI
Nov. 9, 2026

Practice Trade Memecoins and Win Real SOL with memeCI

Indeterminate GlobeNewswire
Leverate Announces Advanced CRM Bringing Intelligent Automation to MT4 and MT5 Brokers
Nov. 9, 2026

Leverate Announces Advanced CRM Bringing Intelligent Automation to MT4 and MT5 Brokers

Indeterminate GlobeNewswire
Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2026
Nov. 9, 2026

Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2026

Indeterminate GlobeNewswire
Oculis to Host In-Person and Virtual R&D Day: Advancing a Differentiated Late-Stage Development Pipeline
Nov. 9, 2026

Oculis to Host In-Person and Virtual R&D Day: Advancing a Differentiated Late-Stage Development Pipeline

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

News Break! Middle East

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.